Collegium Pharmaceutical Inc banner

Collegium Pharmaceutical Inc
F:354

Watchlist Manager
Collegium Pharmaceutical Inc Logo
Collegium Pharmaceutical Inc
F:354
Watchlist
Price: 19.5 EUR 1.04% Market Closed
Market Cap: €637.8m

Wall St Price Targets

Price Forecast
Based on 11 analysts

+250% Upside
from €19.5 today

Collegium Pharmaceutical Inc (354)’s 12-month stock price forecast through October 2027 has a consensus target of €68.2, implying 250% upside. The forecast is based on price targets from 11 Wall Street analysts.

Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for Collegium Pharmaceutical Inc yet.

Collegium Pharmaceutical Inc Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Collegium Pharmaceutical Inc's stock price target?
Price Target
68.2 EUR

According to Wall Street analysts, the average 1-year price target for Collegium Pharmaceutical Inc is 68.2 EUR with a low forecast of 59.88 EUR and a high forecast of 86.86 EUR.

What is the Revenue forecast for Collegium Pharmaceutical Inc?
Projected CAGR
-4%

The compound annual growth rate for Revenue over the next 7 years is -4%.

What is the Gross Profit forecast for Collegium Pharmaceutical Inc?
Projected CAGR
13%

The compound annual growth rate for Gross Profit over the next 5 years is 13%.

What is the Operating Income forecast for Collegium Pharmaceutical Inc?
Projected CAGR
22%

The compound annual growth rate for Operating Income over the next 5 years is 22%.

What is the Pre-Tax Income forecast for Collegium Pharmaceutical Inc?
Projected CAGR
56%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 56%.

What is the Net Income forecast for Collegium Pharmaceutical Inc?
Projected CAGR
38%

The compound annual growth rate for Net Income over the next 5 years is 38%.

Back to Top